Is HJLI or VYM a better dividend investment in 2026?

HJLI currently yields 19.27% with a 5% 5-year dividend growth rate. VYM yields 2.37% with 7.8% growth. The better choice depends on your goal: HJLI offers higher current income.

What is the dividend yield difference between HJLI and VYM?

HJLI has a forward dividend yield of 19.27% ($2.00/share annually). VYM yields 2.37% ($3.51/share annually). The yield gap is 16.90 percentage points.

Home › Compare › HJLI vs VYM

HJLI vs VYM: Dividend Comparison 2026

HJLI yields 19.27% · VYM yields 2.37%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HJLI wins by $42.0K in total portfolio value

INVESTMENT

TIME HORIZON10 years

HJLI

● Live price

19.27%

Share price

$10.38

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$69.8K

Annual income

$6,227.54

Full HJLI calculator →

VYM

Vanguard High Dividend Yield ETF

● Live price

2.37%

Share price

$148.10

Annual div

$3.51

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$27.8K

Annual income

$272.94

Full VYM calculator →

Portfolio growth — HJLI vs VYM

📍 HJLI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HJLI	VYM
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HJLI + VYM cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HJLI pays

VYM pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HJLI

Annual income on $10K today (after 15% tax)

$1,637.76/yr

After 10yr DRIP, annual income (after tax)

$5,293.41/yr

VYM

Annual income on $10K today (after 15% tax)

$201.60/yr

After 10yr DRIP, annual income (after tax)

$232.00/yr

At 15% tax rate, HJLI beats the other by $5,061.41/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HJLI + VYM for your $10,000?

HJLI: 50%VYM: 50%

100% VYM50/50100% HJLI

Portfolio after 10yr

$48.8K

Annual income

$3,250.24/yr

Blended yield

6.66%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on HJLI right now

HJLI

Analyst Ratings

Buy

Consensus: Buy

Altman Z

14.9

Piotroski

3/9

VYM

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HJLI buys

VYM buys

No recent congressional trades found for HJLI or VYM in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHJLIVYM

Forward yield	19.27% ✓	2.37%
Annual dividend / share	$2.00	$3.51 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$69.8K ✓	$27.8K
Annual income after 10y	$6,227.54 ✓	$272.94
Total dividends collected	$38.9K ✓	$2.6K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: HJLI vs VYM ($10,000, DRIP)

Year	HJLI Portfolio	HJLI Income/yr	VYM Portfolio	VYM Income/yr	Gap
1← crossover	$12,627	$1,926.78	$11,147	$237.17	+$1.5K → HJLI
2	$15,784	$2,273.74	$12,404	$242.33	+$3.4K → HJLI
3	$19,546	$2,656.40	$13,780	$247.16	+$5.8K → HJLI
4	$23,988	$3,074.20	$15,285	$251.67	+$8.7K → HJLI
5	$29,193	$3,526.09	$16,932	$255.88	+$12.3K → HJLI
6	$35,247	$4,010.50	$18,733	$259.81	+$16.5K → HJLI
7	$42,240	$4,525.40	$20,701	$263.46	+$21.5K → HJLI
8	$50,265	$5,068.41	$22,852	$266.86	+$27.4K → HJLI
9	$59,421	$5,636.78	$25,201	$270.01	+$34.2K → HJLI
10	$69,808	$6,227.54	$27,768	$272.94	+$42.0K → HJLI

HJLI vs VYM: Complete Analysis 2026

HJLI — Stock

Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. The company is headquartered in Irvine, California and currently employs 9 full-time employees. The firm is developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The firm is in the process of developing bioprosthetic implantable devices for cardiovascular disease. The Company’s Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices. The Company’s product Venous Valve is a bioprosthetic, pig venous valve for patients with lower limb chronic venous insufficiency (CVI), which occurs because of damage to the valves of the veins in the legs after patients develop blood clots in the deep venous system.

Full HJLI Calculator →

VYM — ETF

Seeks to track the performance of the FTSE High Dividend Yield Index, which measures the investment return of common stocks of companies characterized by high dividend yields. Provides a convenient way to track the performance of stocks that are forecasted to have above-average dividend yields. Follows a passively managed, full-replication approach.

Full VYM Calculator →

📬

Get this HJLI vs VYM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HJLI vs SCHD HJLI vs JEPI HJLI vs O HJLI vs KO HJLI vs MAIN HJLI vs VIG HJLI vs DGRO HJLI vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.